tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

RPG Life Sciences Board Clears Q3 and Nine-Month FY26 Unaudited Results

Story Highlights
RPG Life Sciences Board Clears Q3 and Nine-Month FY26 Unaudited Results

Claim 50% Off TipRanks Premium

RPG Life Sciences Limited ( (IN:RPGLIFE) ) has provided an update.

RPG Life Sciences Limited has announced that its Board of Directors, at a meeting held on 27 January 2026, approved the company’s unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. The results, along with the statutory auditors’ limited review reports, have been submitted to the stock exchanges in compliance with SEBI’s Listing Obligations and Disclosure Requirements, underscoring the company’s ongoing financial reporting and regulatory transparency to investors and other stakeholders.

More about RPG Life Sciences Limited

RPG Life Sciences Limited is an Indian pharmaceutical company operating in the life sciences sector, with its equity shares listed on the National Stock Exchange of India (symbol: RPGLIFE) and BSE Limited (scrip code: 532983). The company is part of the listed corporate ecosystem and is subject to the Securities and Exchange Board of India’s listing and disclosure regulations.

Average Trading Volume: 1,523

Technical Sentiment Signal: Buy

Current Market Cap: 35.32B INR

Learn more about RPGLIFE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1